chrisvoncsefalvay/vaers-outcomes huggingface dataset:
?COVID arm? The site of the injection began to itch (sometimes awakening me from sleep) and continued for about two days
I started to lose my appetite three days after the first dose of the vaccine. Four days after the shot I started to get headaches. At first, they were light headaches but then I got fatigue, nausea, brain fog and I was in bed for 3 days. I was having sharp shooting chest pain went to the ER on 09/14/2021. I was given steroids, Benadryl. I have been tested for Covid-19 twice since my vaccine. I have been having the headaches for over four weeks and they are better some days than others. I still get fatigue and chills intermittently every few days. They are lasting a little less time but the headaches, fatigue and chills mean I have to go to bed. The headaches move from one part of my head to another. Today it is at the front of my head. The brain fog with my headache is so bad that I can't concentrate on anything. I can't hold a conversation, watch tv or read. I have been unable to work much since I got my shot.
A week after the 1st dose he had a HSV-2 outbreak; This spontaneous case was reported by a non-health professional and describes the occurrence of HERPES SIMPLEX (A week after the 1st dose he had a HSV-2 outbreak) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G20A) for COVID-19 vaccination.     The patient's past medical history included HSV infection.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced HERPES SIMPLEX (A week after the 1st dose he had a HSV-2 outbreak). The patient was treated with ACYCLOVIR [ACICLOVIR] for HSV infection, at an unspecified dose and frequency. At the time of the report, HERPES SIMPLEX (A week after the 1st dose he had a HSV-2 outbreak) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       The treatment history was not reported. The concomitant medication was not reported. Before getting the vaccine patient used to have 1-2 outbreaks a year and Patients had needed Acyclovir which didn't use before.   This case was linked to MOD-2021-293081 (Patient Link).
This spontaneous report was received from a registered nurse refers to a female patient of an unknown age. The patient's relevant medical history, concurrent condition and concomitant medication were not reported. On an unknown date in April-2018, the patient was inadvertently vaccinated with ZOSTAVAX vial 19400 plaque-forming unit (PFU), lot # N014942 (expiry date: 02-FEB-2018), subcutaneously (deltoid) for prophylaxis (dose not reported) instead of VARIVAX (wrong vaccine administered and expired vaccine used). The patient attempted to conceive at this time however, the patient was not pregnant at this time. No adverse events. No product quality complaint (PQC) was involved.
Inflamed Left Forearm, Left Hand, and Left foot; Redness of left forearm, left hand, and left foot; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Inflamed Left Forearm, Left Hand, and Left foot) and ERYTHEMA (Redness of left forearm, left hand, and left foot) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced INFLAMMATION (Inflamed Left Forearm, Left Hand, and Left foot) and ERYTHEMA (Redness of left forearm, left hand, and left foot). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, INFLAMMATION (Inflamed Left Forearm, Left Hand, and Left foot) and ERYTHEMA (Redness of left forearm, left hand, and left foot) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Follow-up contains no new information; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Decreased talked, severe jerking movements when sleeping (never happened prior), waking up screaming, seems to be in pain, decrease in motor skills, was walking no longer doing so.
Moderna COVID-19 Vaccine EUA.  24 hours after receiving the vaccine I experienced extreme fatigue and dizziness for approximately 90 minutes.  I also encountered soreness at the injection site.  Not a problem.  Other than that, I felt fine.  Thank you.
dizziness; nausea; headache; heart was pounding (HR 98); This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heart was pounding (HR 98)), DIZZINESS (dizziness), NAUSEA (nausea) and HEADACHE (headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced HEART RATE INCREASED (heart was pounding (HR 98)). On an unknown date, the patient experienced DIZZINESS (dizziness), NAUSEA (nausea) and HEADACHE (headache). On 17-Mar-2021, HEART RATE INCREASED (heart was pounding (HR 98)) had resolved. At the time of the report, DIZZINESS (dizziness), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Information has been received from a nurse practitioner concerning a 16 year old female patient with no pertinent medical history and no drug reactions who on 19-MAY-2009 was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL (lot# not reported). On 14-OCT-2009 the patient was vaccinated intramuscularly with the second 0.5ml dose of GARDASIL (lot# 660612/0229X). There was no concomitant medication. On 14-OCT-2009 the patient developed a fever of 101F and body aches. Unspecified medical attention was sought via office visit. On 17-OCT-2009, the patient recovered. Follow-up information has been received from the nurse concerning the 16 year old female patient who on 19-MAY-2009 was vaccinated intramuscularly with the first 0.5ml dose of GARDASIL (lot# 662229/1497X), and concomitantly was vaccinated with a dose of HAVRIX (lot# HHHVBZ96AA), a dose of MENACTRA (lot# U2524AA), and a dose of ADACEL (lot# UF460BA). On 14-OCT-2009 the patient was vaccinated with the second dose of GARDASIL (lot# 660612/0229X) and did not received any concomitant vaccinations at that time. The nurse stated that she had spoken to the patient and the patient had recovered. Additional information is not expected.
Pt. says she had shooting pain in left arm till middle finger. Used ADVIL for relief and slowly recovering.
Hot flashes several times a day/night; This is a spontaneous report from a non contactable consumer, the patient. A 39-year-old non-pregnant female patient was received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; lot number: EN 6206) via an unspecified route of administration in left arm on 12Mar2021 at 13:00 hours for COVID-19 immunisation. Medical history included raynauds. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not tested positive for COVID-19 since the vaccination. On 12Mar2021, at 14:00 hours the patient experienced hot flashes several times a day/night for a full week since she got the first dose. They are tolerable but the patient never had them before. The patient underwent tab tests and procedures, which included COVID-19 virus test on 17Mar2021 and tested negative. No therapeutic measures were taken as a result of adverse event. The clinical outcome of the event hot flashes was not resolved at the time of reporting.    No follow-up attempts are needed. No further information is expected.
only had a little headache after the first two doses; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (only had a little headache after the first two doses) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 010M20A) for COVID-19 vaccination.     The patient's past medical history included Muscle relaxant since an unknown date. Concurrent medical conditions included Allergy to chemicals (Iodine). Concomitant products included TIZANIDINE for Muscle relaxant.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced HEADACHE (only had a little headache after the first two doses). At the time of the report, HEADACHE (only had a little headache after the first two doses) outcome was unknown.            No treatment medications was reported.   This case was linked to MOD-2022-668059 (Patient Link).
Low grade fever after booster shot; This spontaneous case was reported by a physician and describes the occurrence of PYREXIA (Low grade fever after booster shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Low grade fever after booster shot). At the time of the report, PYREXIA (Low grade fever after booster shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not provided.   Reporter did not allow further contact
Minor tongue and lip swelling occurred within minutes.  I was monitored for 30 minutes and swelling didn't appear life threatening.  2 hours after vaccination I broke out in hives and my blood pressure dropped significantly.  Since then, I have been taking Benadryl regularly to control hives and tongue/lip swelling.  Additionally, I have stopped my blood pressure medication due to my blood pressure jumping from very low (68.42 at the lowest) to normal range (115/76 highest).  This has resulted in severe dizziness.   Primary doctor advised this morning (Monday - 2 days after shot) to simply monitor blood pressure and continue taking Benadryl.  Allergist advised going to ER due to blood pressure.  Neither is willing to change their vote... As I'm currently handling all symptoms, I'm choosing to skip the ER for now unless I have another extreme drop in BP. I also had the "normal" vaccine reactions of severe headache, body aches, and fever.
Information has been received from a registered nurse concerning a 34 year old male patient with no known drug allergies who on Jan 10, 2003, in the pm, was vaccinated IM in the left deltoid with a first dose of pneumococcal vaccine 23 polyvalent (lot #644104/0873M). It was noted that the patient had a upper respiratory infection at the time of vaccination. Subsequently the patient experienced a red, big, swollen arm that was warm to the touch. It as noted that he had a fever of 103 degrees F and his vaccinated arm was the size of a grapefruit at the injection site. The patient sought medical attention at the physician's office, but the nurse did not know what interventions were recommended by the doctor. The reporter would like a lot check. Follow up information indicated that on Jan 11, 2003, and Jan 12, 2003 in the am, the patient developed a fever of 103 F, was achy, fatigued, and had a red, swollen ,and hard left deltoid. It was noted that the patient recovered on Jan 15, 2003. It was noted that the patient did not seek medical attention as previously reported. No further information is available.
MY HAND AND FINGERS FELT RIGID AND PAINFUL IN ALL THE JOINTS. I COULD NOT MOVE MY FINGERS. AT THE SAME TIME I HAD AN INTENSE CRAMP ON MY THIGHS WITH THE MUSCLES VERY TIGHT, IT LASTED ABOUT THREE HOURS.
Poison ivy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-healthcare professional) from medical information team. The reporter is the patient. A 67-year-old male patient received bnt162b2 (BNT162B2), administration date 23Mar2021 (Batch/Lot number: Unknown) at the age of 67 years as dose 1, single for covid-19 immunisation. The patient relevant medical history and concomitant medications were not reported. The following information was reported: DERMATITIS CONTACT (non-serious) with onset Mar2021, outcome "unknown", described as "Poison ivy".  Additional information: Patient was scheduled to receive his second dose on 20Apr2021. The caller stated that he has poison ivy and he needs a steroid injection. He would like to know if it's okay to take this steroid shot prior to receiving the second dose of the Pfizer COVID-19 vaccine.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
The same day of vaccination, I started having a metallic taste in my mouth, a painful burning rash from head to toe, muscle aches, sweats, exhaustion, severe headaches and a fever of 103 thru out the night, Then the following day I developed golf ball sized swelling in both sides of my neck, (lymph nodes) and under both of my arms. Then I started having rashes daily. I went to an urgent care 4 -5 weeks after vaccination and they started me on prednisone. Then, I had to go back in to see them because I could not take the prednisone. They put me on Allegra and Prilosec. That did not help so I went to see my (PCP) in August who switched me out to Zyrtec and it did not help either. I still have itchy, burning rashes (sometimes they are spots and sometimes they are whelps) periodically and the metallic taste in my mouth.
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: HOT TO TOUCH-Medium
Got severe left side lower back pain which initially I thought was a muscle pain which got cured with medication . But later pain moved over to right side hip,  thigh , upper and lower leg .This pain though low grade is persisting  and  causes lot of discomfort . No medication has been taken for this pain . Also I my mouth saliva became sticky with thick phlegm which collects in throat and needs to be cleared frequently . I have //had no cough/cold . It is not getting cured inspite of taking cough drops or cough medication . This condition is not  reported to doctor. Medicines:  Naproxen , Cyclobenzapr
Pt says she had itching after the vaccine was administered. One week later, 8/16/2021 she had facial redness and facial swelling-- face felt tight; swollen appearance noted by husband around 5 pm.
Pt became pale, lethargic, cried constantly, developed fever 101 R; sx devel w/in a few hrs of receiving vax; Seen by family MD who requests subsequent use of Pediatric DT;
ENTIRE BODY TURNED RED, BROKE OUT IN HIVES ALL OVER BODY, ITCHY, SWELLING TO LIPS AND EYES. 5 ML BENADRYL GIVEN ORALLY, SYMPTOMS DECREASED WITHIN 1 HOUR AND GRADUALLY IMPROVED THROUGHOUT DAY.
Chills, Fever, Body Aches, Head Aches, and Extreme Fatigue
3 cm x 3 cm red, firm, warm circular area on upper left thigh.
lt leg devel area of bruising, raised w/small welts inside bruise; sore; high fever 102.9 p/vax;
No additional AE details; TE evaluation states vaccines have been administered to multiple patients; This spontaneous report was received from a medical assistant and referred to a 1-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 23-MAR-2022, the temperature excursion (-14 degree Celsius up to -10 degree Celsius for 3 hours) occurred of varicella virus vaccine live (oka/merck) (VARIVAX). On 27-APR-2022, the patient was vaccinated with the varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection for prophylaxis (lot #U025790, expiration date: 19-AUG-2023; strength and dose were not provided) (product storage error). No additional adverse event (no adverse event) was reported. The reporter contacted company and verified the viability of vaccine; the vaccine was not available for return or evaluation because it was given to the patient.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2204USA009330:
leaking when administered; leaking issue; Product Complaint; This case was reported by a nurse via call center representative and described the occurrence of incomplete dose administered in a patient who received DTPa (Reduced antigen) (Boostrix) (batch number 22MS7, expiry date 1st April 2024) for prophylaxis. This case was associated with a product complaint.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced incomplete dose administered, syringe connection issue and pharmaceutical product complaint. On an unknown date, the outcome of the incomplete dose administered, syringe connection issue and pharmaceutical product complaint were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 1-Jul-2022  Reporter's comment: The nurse from the clinic reported that 3 doses of Boostrix were leaking from the connection hub when administered to 3 different patients. The reporter was unable to confirm what type needle was attached to the syringe for the administration but stated that the luer lock device appeared to be attached crooked.  The content questions were asked as  where did the vaccine leak,  at the luer lock connection hub.  The syringe was not pre-assembled with needle some time before administration.  The size of gauge needle was uncertain.  The reporter will call back with additional information when she returns to the office.  The reporter believed it was 22G. Product quality complaint was filed. No blister and/or carton damaged.  No luer lock was damaged.  The needle used to administer was discarded in sharps container but the reporter will return an unused needle of the same type that was used during administration.  The reporter reported that she had emailed in pictures and might be attached to parent case.  The reporter was unable to provide GlaxoSmithKline information and will call back with information.  The reporter did not have specific patient identifiers.  No further information provided.  The consent to contact patient's health care professional unable to be obtained. Additional supportive information: The vaccine was leaking from the connection hub when administered to the patient which led to incomplete dose administered and syringe connection issue. The case was 2 of 3 linked cases. Follow-up request was raised for the patient's gender.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022103828:Same reporter US-GLAXOSMITHKLINE-US2022AMR104308:Same reporter
Low Blood Plattlet Count  Causing 4 days in Hosp. Because of unexplained brusing  Received blood products to raise count. am still under dr. care
Rectangular area R torso, impetiginous lesion at center; dry skin on chest, R antecub, R back, finger , toe - DX:  SHINGLES- VACCINE INDUCED.
04/12/2022 vaccination. 07/12/2022 I was talking with one of my co-workers. I was standing up. All of a sudden I started to get dizzy, felt like I had been spinning myself. I sat down at my desk. It kept occurring and I felt nauseated. I felt I had to go to the emergency room. They gave me some medication to stop the nausea and to help with the spinning. My vitals were ok except my blood pressure was 150/121. They did every kind of test on me. Test results. Tear in the nerve in my brain; near TIA. I have to keep on medication to solve the problem. Seeing a neurologist and keep medication 6-8 weeks. Not ruled out that I won't have a TIA during this time.
3 hours post injection had pain in arm 15 hours post injection experienced chills, nausea, weakness, shaky feeling, nasal congestion, headache, temperature 102.5 degrees F, migratory pain.
Large red and itchy mosquito bite bump appeared at injection site. Swelling lasted for 24-hrs, then subsided into red circle, then a red ring, then disappeared.
Within minutes of the injection, shoulder pain started and hasn't resolved, now fourth week later.  Symptoms: dull ache in right shoulder, twinging pain with lifting arm, inability to use arm for some daily functions due to pain/weakness, pain at night, pain with palpatations at site of injection, treatment so far - ice or heat, ROM, Ultrasound.
I had a fever of 102.1. My arm was very, very sore and I had a headache for a week with extreme fatigue and chills. In addition I had Tinnitus and a post nasal drip to the point of where I lost my voice, muscle aches were also a factor.